Evoke Pharma Revenue and Competitors

Solona Beach, CA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Evoke Pharma's estimated annual revenue is currently $4.3M per year.(i)
  • Evoke Pharma's estimated revenue per employee is $155,000

Employee Data

  • Evoke Pharma has 28 Employees.(i)
  • Evoke Pharma grew their employee count by 8% last year.

Evoke Pharma's People

NameTitleEmail/Phone
1
Founder & CEOReveal Email/Phone
2
CEOReveal Email/Phone
3
Chief Commercial OfficerReveal Email/Phone
4
VP FinanceReveal Email/Phone
5
Chief Medical OfficerReveal Email/Phone
6
Early Intervention Account ManagerReveal Email/Phone
7
Regional Sales TrainerReveal Email/Phone
8
Gastroenterology Care SpecialistReveal Email/Phone
9
Gastroenterology Care SpecialistReveal Email/Phone
10
Gastroenterology Care SpecialistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.4M70-8%$53MN/A
#2
$32.4M167-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.8M1813%N/AN/A
#5
$0.8M5-50%N/AN/A
#6
$0.8M100%N/AN/A
#7
$14M90-12%N/AN/A
#8
$0.4M33610%$236.7MN/A
#9
$4.8M62-74%$160MN/A
#10
$3.7M24-8%N/AN/A
Add Company

What Is Evoke Pharma?

Evoke Pharma is a Biotechnology company located in 505 Lomas Santa Fe Dr, Solana Beach, California, United States.

keywords:N/A

N/A

Total Funding

28

Number of Employees

$4.3M

Revenue (est)

8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Evoke Pharma News

2022-04-17 - Evoke Pharma Announces Approval of GIMOTI® to the Texas ...

About Evoke Pharma, Inc. Evoke is a specialty pharmaceutical company focused primarily on the development of drugs to treat GI disorders and...

2022-04-17 - Evoke Pharma Inc (EVOK) Stock Increases 2.56% This Week; Should You Buy?

Evoke Pharma Inc (EVOK) stock has fallen -75.61% over the last 12 months. InvestorsObserver's proprietary ranking system, gives EVOK stock a...

2022-04-17 - Short Interest in Evoke Pharma, Inc. (NASDAQ:EVOK) Drops ...

Renaissance Technologies LLC purchased a new stake in Evoke Pharma during the fourth quarter valued at about $25,000. Geode Capital Management...